Paul Brennan

Biography

Mr. Brennan brings more than 25 years of experience in building and leading pharmaceutical and biotechnology companies in the United States, Europe, and Canada with a strong track record in partnering and licensing transactions. Previously, Mr. Brennan was Senior Vice President of Business Development at Arbutus Biopharma Corp. (formerly Tekmira Pharmaceuticals Corp.), prior to which he served as CEO of Altair Therapeutics, Inc. In past roles Mr. Brennan contributed to the sale of Aspreva Pharmaceuticals Corp. to Vifor Pharma Ltd. for $915 million and the sale of AnorMED Inc. to Genzyme Corp. for $580 million. Mr. Brennan also served in senior business development and regulatory affairs roles with AstraZeneca PLC, operating in Sweden, the United Kingdom, and Canada. 

Research Interest

Biochemistry